Medpace Holdings, Inc. stock is up 5.19% since 30 days ago. The next earnings date is Feb 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 87.5% of the previous 7 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
03 Nov 15:19 | 15 Dec, 2023 | 250.00 | 233 | ||
07 Nov 20:59 | 15 Dec, 2023 | 250.00 | 106 | ||
08 Nov 17:32 | 15 Mar, 2024 | 260.00 | 142 | ||
15 Nov 16:26 | 15 Dec, 2023 | 270.00 | 199 | ||
16 Nov 17:34 | 17 Nov, 2023 | 270.00 | 195 | ||
16 Nov 17:36 | 15 Dec, 2023 | 300.00 | 300 | ||
17 Nov 14:38 | 15 Dec, 2023 | 270.00 | 178 | ||
17 Nov 19:48 | 17 Nov, 2023 | 270.00 | 141 | ||
22 Nov 19:12 | 15 Dec, 2023 | 270.00 | 247 | ||
04 Dec 20:02 | 15 Dec, 2023 | 270.00 | 193 |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company was founded in 1992 and is based in Cincinnati, Ohio.